• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by AirSculpt Technologies Inc.

    2/14/23 1:55:50 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care
    Get the next $AIRS alert in real time by email
    SC 13G 1 schedule13g.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549
     
    SCHEDULE 13G
     
    Under the Securities Exchange Act of 1934
    (Amendment No. __)*
     
    AirSculpt Technologies, Inc.
    (Name of Issuer)
     
    Common Stock, $0.001 par value per share
    (Title of Class of Securities)
     
    009496100
    (CUSIP Number)
     
    December 31, 2022
    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     

    [ X ]
    Rule 13d-1(b)
     

    [_]
    Rule 13d-1(c)
     

    [_]
    Rule 13d-1(d)
     
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Exchange Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     

    CUSIP No. 009496100
     
    1
    NAMES OF REPORTING PERSONS.

    Thrivent Financial for Lutherans

    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐  (b) ☐
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Wisconsin
     
    NUMBER OF
    SHARES
    BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
    0
     
    6
    SHARED VOTING POWER
    5,169,819(1)
     
    7
    SOLE DISPOSITIVE POWER
    0
     
    8
    SHARED DISPOSITIVE POWER
    5,169,819 (1)
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    5,169,819 (1)
     
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
     ☐
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    9.2%2
     
    12
    TYPE OF REPORTING PERSON (See Instructions)

    IC, IA

     



    (1) Consists of 5,169,819 shares of Common Stock of the Issuer (the “Issuer Shares”) held indirectly by Thrivent White Rose Fund XI Equity Direct, L.P. (“White Rose”) through its approximate 45.5% ownership interest in EBS Aggregator Blocker Holdings, LLC (“EBS”).  Thrivent Financial for Lutherans is also the managing member of the general partner of White Rose, Thrivent White Rose GP XI, LLC, and the owner of approximately 99% of the limited partnership interests of White Rose.
     
    Thrivent Financial for Lutherans is the investment adviser of White Rose, and in that capacity has been granted by White Rose shared authority to vote and dispose of White Rose’s ownership interest in EBS with Vesey Street Capital Partners, L.L.C., the Manager of EBS. Pursuant to a letter agreement dated October 27, 2021, as amended, among EBS, Vesey Street Capital Partners, L.L.C., affiliated entities, and White Rose, White Rose has the right to request at any time, all or a portion of its Issuer Shares held directly by EBS be released directly to White Rose within one (1) business day of such request.

    (2) This percentage is calculated based on 56,172,447 shares of the Issuer’s Common Stock reported to be outstanding as of November 11, 2022 on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2022.

    Item 1.
    (a)   Name of Issuer:

    AirSculpt Technologies, Inc.

    (b)   Address of Issuer’s Principal Executive Offices:

    c/o AirSculpt Technologies, Inc.
    400 Alton Road, Unit TH-103M
    Miami Beach, Florida
     
    Item 2.
    (a)   Name of Person Filing:

    Thrivent Financial for Lutherans

    (b)   Address of Principal Business Office or, if None, Residence:

    901 Marquette Avenue, Suite 2500
    Minneapolis, Minnesota 55402

    (c)   Citizenship:

    Thrivent Financial for Lutherans is a Wisconsin fraternal benefit society.

    (d)   Title of Class of Securities:

    Common Stock, $0.001 par value per share

    (e)   CUSIP Number:

    009496100
     
    Item 3.
    If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
     
     
    (a)
    ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
         
     
    (b)
    ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
         
     
    (c)
    ☒ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
         
     
    (d)
    ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
         
     
    (e)
    ☒ Investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
         
     
    (f)
    ☐ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
         
     
    (g)
    ☐ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
         


     
    (h)
    ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
         
     
    (i)
    ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
         
     
    (j)
    ☐ Group, in accordance with § 240.13d-1(b)(1)(ii)(J).

    Item 4.
    Ownership.
     

    (a)
    Amount beneficially owned:  5,169,819(1)
     

    (b)
    Percent of Class: 9.2%(2)
     

    (c)
    Number of shares as to which the person has:
     

    (i)
    Sole power to vote or to direct the vote:  0
     

    (ii)
    Shared power to vote or to direct the vote:  5,169,819(1)
     

    (iii)
    Sole power to dispose or to direct the disposition of:  0
     

    (iv)
    Shared power to dispose or to direct the disposition of:  5,169,819(1)
     
    Item 5.
    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.
     
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.

    Thrivent Financial for Lutherans is the investment adviser of White Rose.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not applicable.
     
    Item 8.
    Identification and Classification of Members of the Group.

    Not applicable.
     
    Item 9.
    Notice of Dissolution of Group.

    Not applicable.
     

     
    _____________________________________
     
    (1) See Note 1 on the cover page.
     
    (2) See Note 2 on the cover page.

    Item 10.
    Certifications.
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
     
    SIGNATURE
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
    Dated:  February 14, 2023
     
    Thrivent Financial for Lutherans

    By: /s/ David S. Royal
    Name: David S. Royal
    Title: Executive Vice President, Chief Financial and Investment Officer
     

    Get the next $AIRS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIRS

    DatePrice TargetRatingAnalyst
    10/17/2024Neutral
    BTIG Research
    5/14/2024$8.25 → $5.00Outperform → Market Perform
    Leerink Partners
    11/11/2022$4.00Overweight → Neutral
    Piper Sandler
    6/16/2022$17.00 → $8.50Overweight → Equal-Weight
    Morgan Stanley
    11/23/2021$18.00Outperform
    Raymond James
    11/23/2021$17.00Overweight
    Morgan Stanley
    11/23/2021$26.00Outperform
    SVB Leerink
    11/23/2021$22.00Overweight
    Piper Sandler
    More analyst ratings

    $AIRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Feinstein Adam T bought $4,000,000 worth of shares (1,000,000 units at $4.00) (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    6/11/25 5:06:44 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Executive Chairman Rollins Aaron bought $7,629 worth of shares (2,118 units at $3.60), increasing direct ownership by 0.01% to 15,146,039 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    5/20/25 4:11:19 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Jashnani Yogesh bought $18,532 worth of shares (7,000 units at $2.65), increasing direct ownership by 2% to 464,879 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    5/7/25 5:56:15 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Feinstein Adam T bought $4,000,000 worth of shares (1,000,000 units at $4.00) (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    6/11/25 5:06:44 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Executive Chairman Rollins Aaron bought $7,629 worth of shares (2,118 units at $3.60), increasing direct ownership by 0.01% to 15,146,039 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    5/20/25 4:11:19 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Director Chu Caroline was granted 58,594 shares, increasing direct ownership by 50% to 176,780 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    5/8/25 7:55:44 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on AirSculpt Technologies

    BTIG Research initiated coverage of AirSculpt Technologies with a rating of Neutral

    10/17/24 7:13:51 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded AirSculpt Technologies from Outperform to Market Perform and set a new price target of $5.00 from $8.25 previously

    5/14/24 7:53:44 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded AirSculpt Technologies from Overweight to Neutral and set a new price target of $4.00

    11/11/22 3:44:11 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Leadership Updates

    Live Leadership Updates

    View All

    AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer

    MIAMI BEACH, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced the appointment of Yogi Jashnani as Chief Executive Officer ("CEO") and a member of the Board of Directors. He succeeds Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer who will continue as Chief Financial Officer, all effective January 7, 2025. A highly-talented, results oriented executive with an accomplished career spanning more than two decades, Mr. Jashnani has architected successful transformations for public and private companies in the aesthetics

    12/17/24 6:45:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    SEC Filings

    View All

    SEC Form 10-Q filed by AirSculpt Technologies Inc.

    10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)

    8/1/25 3:43:27 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

    8/1/25 3:38:52 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

    8/1/25 6:06:52 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AirSculpt Technologies Announces Participation in Sidoti Micro Cap Conference

    MIAMI BEACH, Fla., Aug. 13, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced that the Company will participate in the Sidoti Micro Cap Conference being held virtually from August 20 to 21, 2025. Management will meet with investors throughout both days and host a presentation at 10:00am ET on Wednesday, August 20. The presentation will be webcast live at https://investors.airsculpt.com. An archive of the webcast presentation will be available for 90 days. About AirSculpt AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and

    8/13/25 6:00:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results

    MIAMI BEACH, Fla., Aug. 01, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter ended June 30, 2025. The Company also announced that Dennis Dean intends to retire from his position of Chief Financial Officer. Mr. Dean will retain his role until a permanent successor is in place. Yogi Jashnani, Chief Executive Officer, stated: "In an ongoing dynamic environment, the second quarter saw us advance our transformation initiatives, and based on our results and our outlook, we remain on track to achieve our annual guidance. We narrowed our year-

    8/1/25 6:00:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Announces Second Quarter Fiscal 2025 Earnings Release Date and Conference Call

    MIAMI BEACH, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), an industry leader and provider of premium body contouring procedures, today announced it will report second quarter 2025 financial results before market open on Friday, August 1, 2025, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13754561 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Air

    7/25/25 6:45:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AirSculpt Technologies Inc.

    SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)

    11/8/24 8:42:05 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by AirSculpt Technologies Inc. (Amendment)

    SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)

    2/14/24 1:11:48 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by AirSculpt Technologies Inc.

    SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)

    4/27/23 9:49:49 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    Financials

    Live finance-specific insights

    View All

    AirSculpt Technologies Announces Second Quarter Fiscal 2025 Earnings Release Date and Conference Call

    MIAMI BEACH, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), an industry leader and provider of premium body contouring procedures, today announced it will report second quarter 2025 financial results before market open on Friday, August 1, 2025, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13754561 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Air

    7/25/25 6:45:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance

    MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2025. "We began the year reporting results in line with our expectations, and while we are early in our transformation, I am encouraged by the progress the team has made on the business imperatives we set in place at the start of the year and I remain confident that we have identified and are implementing the right actions to return to growth," stated Yogi Jashnani, Chief Executive Officer. "To this end, the first quarter saw profitability

    5/2/25 6:00:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call

    MIAMI BEACH, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2025 financial results before market open on Friday, May 2, 2025, to be followed by a conference call on the same day at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13753206 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirScul

    4/25/25 6:45:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care